|
8,465,733
|
Pharmaceutical composition containing human mesenchymal stem cell |
Oct 27, 08 |
Jun 18, 13 |
, JCR PHARMACEUTICALS CO. LTD. |
|
8,465,780
|
Borate micro emulsion and method for making the same |
Feb 19, 10 |
Jun 18, 13 |
, NISUS CORPORATION |
|
8,466,086
|
Nutritive media and manufactured seeds comprising same |
Feb 20, 03 |
Jun 18, 13 |
, WEYERHAEUSER NR COMPANY |
|
8,466,087
|
Seed treatment compositions and methods |
Sep 03, 10 |
Jun 18, 13 |
, FBSCIENCES HOLDINGS, INC. |
|
8,466,088
|
Herbicidal compositions containing benzoylpyrazole compounds |
Feb 01, 08 |
Jun 18, 13 |
, ISHIHARA SANGYO KAISHA LTD. |
|
8,466,089
|
Pyrazole compounds, process for their production and herbicides containing them |
May 19, 09 |
Jun 18, 13 |
, ISHIHARA SANGYO KAISHA LTD. |
|
8,466,113
|
4-isopropylphenyl glucitol compounds as SGLT1 inhibitors |
Feb 23, 10 |
Jun 18, 13 |
, TAISHO PHARMACEUTICAL CO. LTD. |
|
8,466,114
|
Glycoside derivatives and uses thereof |
Mar 21, 12 |
Jun 18, 13 |
, NOVARTIS AG |
|
8,466,116
|
Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
Sep 05, 08 |
Jun 18, 13 |
, THE UNITES STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
|
8,466,118
|
Modulation of blood brain barrier protein expression |
Apr 23, 08 |
Jun 18, 13 |
, SAINT LOUIS UNIVERSITY |
|
8,466,121
|
Method of selectively inhibiting the activity of ACAT1 in the treatment of Alzheimer's disease |
Mar 28, 11 |
Jun 18, 13 |
, TRUSTEES OF DARTMOUTH COLLEGE |
|
8,466,130
|
Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
Sep 04, 09 |
Jun 18, 13 |
, COLBY PHARMACEUTICAL COMPANY; MEDICAL COLLEGE OF WISCONSIN INC.; |
|
8,466,133
|
Polylactides compositions and uses thereof |
Apr 21, 06 |
Jun 18, 13 |
, UNIVERSITY OF GENEVA |
|
8,466,134
|
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
Jun 24, 99 |
Jun 18, 13 |
, ATHENA NEUROSCIENCES INC. |
|
8,466,140
|
Mitochondria-targeted anti-tumor agents |
Sep 10, 08 |
Jun 18, 13 |
, UNIVERSITY OF MASSACHUSETTS |
|
8,466,141
|
Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
May 22, 09 |
Jun 18, 13 |
, MD BIOALPHA CO. LTD.; KT&G CO., LTD.; |
|
8,466,150
|
Inhibitors of poly(ADP-ribose)polymerase |
Jun 12, 08 |
Jun 18, 13 |
, ABBOTT LABORATORIES |
|
8,466,151
|
Compounds and method for treatment of cancer |
Dec 24, 08 |
Jun 18, 13 |
, CRITICAL OUTCOME TECHNOLOGIES, INC. |
|
8,466,160
|
Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha |
Dec 30, 10 |
Jun 18, 13 |
, CELL SIGNALING TECHNOLOGY INC. |
|
8,466,162
|
5-alkynyl-pyridines |
Jan 24, 12 |
Jun 18, 13 |
, BOEHRINGER INGELHEIM INTERNATIONAL GMBH |